Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China flag China · Delayed Price · Currency is CNY
2.580
-0.060 (-2.27%)
Apr 9, 2026, 11:29 AM CST
Market Cap8.41B +7.0%
Revenue (ttm)1.75B -16.9%
Net Income-357.09M
EPS-0.11
Shares Out3.18B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume57,339,596
Average Volume55,503,225
Open2.620
Previous Close2.640
Day's Range2.570 - 2.680
52-Week Range2.120 - 3.230
Beta0.22
RSI58.29
Earnings DateMar 31, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicines; and xueshuantong for shooting, zhonghua dieda pills, angong niuhuang pills, shedan chuanbei liquid, fuyanjing capsules, jieshitong tablets, yanjianning tablets, sodium fluorescein injection under the Zhonghua, Chenzhong, and Zhongheng brands for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics,ophthalmology, gynecology, ediatric... [Read more]

Sector Healthcare
Founded 1993
Employees 2,971
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600252
Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -23.00% compared to the previous year's 2.27 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements